ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,515, issued on May 20, was assigned to City University of Hong Kong (Hong Kong).
"PIM1 inhibitors for use in treatment of viral infection and pharmaceutical compositions thereof" was invented by Ming-Liang He (Hong Kong), Ying Chen (Hong Kong), Fanghang Zhou (Hong Kong) and Qianya Wan (Hong Kong).
According to the abstract* released by the U.S. Patent & Trademark Office: "A Pim-1 proto-oncogene, serine/threonine kinase (PIM1) inhibitor for use in the treatment of a viral infection or use of said PIM1 inhibitor in the preparation of a medicament for said treatment. A method of treating a human afflicted with a viral infection. The method comprises administering, to the human, an e...